Literature DB >> 3281823

PAF antagonists. Their potential therapeutic role in asthma.

K F Chung1, P J Barnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3281823     DOI： 10.2165/00003495-198835020-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  97 in total

1.  Recurrent nocturnal asthma after exposure to grain dust.

Authors:  R J Davies; M Green; N M Schofield
Journal:  Am Rev Respir Dis       Date:  1976-11

2.  Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.

Authors:  H Darius; D J Lefer; J B Smith; A M Lefer
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  Reduction of bronchial hyperreactivity during prolonged allergen avoidance.

Authors:  T A Platts-Mills; E R Tovey; E B Mitchell; H Moszoro; P Nock; S R Wilkins
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

Review 4.  The changing face of asthma.

Authors:  P J Barnes
Journal:  Q J Med       Date:  1987-05

Review 5.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

6.  AGEPC (platelet activating factor) induced stimulation of rabbit platelets: effects on phosphatidylinositol, di- and triphosphoinositides and phosphatidic acid metabolism.

Authors:  S D Shukla; D J Hanahan
Journal:  Biochem Biophys Res Commun       Date:  1982-06-15       Impact factor: 3.575

7.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

8.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

9.  Asthma as an axon reflex.

Authors:  P J Barnes
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

10.  trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.

Authors:  S B Hwang; M H Lam; T Biftu; T R Beattie; T Y Shen
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157
View more
  6 in total

Review 1.  Treatment of bronchospastic disorders in the 1990s. What does the future hold?

Authors:  P G Gianaris; J A Golish
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

Review 2.  Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

Authors:  S M Grant; K L Goa; A Fitton; E M Sorkin
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 3.  New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future.

Authors:  V A Alabaster; B A Moore
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

4.  Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.

Authors:  R Korth; M Hirafuji; C L Keraly; D Delautier; J Bidault; J Benveniste
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 5.  Pharmacology of airway inflammation in asthma.

Authors:  K F Chung
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 6.  Role for platelet-activating factor in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.